- Corporate Officers - C
- Craves Fred B
Insider Trading History of Craves Fred B
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Craves Fred B since 2006.
This trader's CIK number is 1014095.
At the time of last reporting, Craves Fred B was the Director of Madrigal Pharmaceuticals, Inc.. (stock ticker symbol MDGL).
Also see all insider trading activities at Madrigal Pharmaceuticals, Inc..
Note that in the past
CRAVES FRED B also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Madrigal Pharmaceuticals, Inc. (MDGL) by Craves Fred B
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | MDGL | 0 | $0 | 15,470 | $5,098,544 | 15,470 | $1,184,221 |
| 2024 | MDGL | 0 | $0 | 26,089 | $5,980,228 | 22,489 | $2,311,082 |
| 2020 | MDGL | 0 | $0 | 30,000 | $3,292,194 | 0 | $0 |
| 2019 | MDGL | 0 | $0 | 1,200,000 | $126,564,000 | 0 | $0 |
| 2018 | MDGL | 2,000 | $248,494 | 280,000 | $80,488,800 | 0 | $0 |
Yearly summary of insider trading at Dermira, Inc. (DERM) by Craves Fred B
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | DERM | 0 | $0 | 0 | $0 | 3,000 | $0 |
| 2018 | DERM | 0 | $0 | 0 | $0 | 3,000 | $0 |
| 2017 | DERM | 30,000 | $690,940 | 0 | $0 | 0 | $0 |
| 2014 | DERM | 69,112 | $1,105,792 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Neorx Corp (PARD) by Craves Fred B
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2011 | PARD | 0 | $0 | 0 | $0 | 36,145 | $0 |
| 2009 | PARD | 20,000 | $42,083 | 0 | $0 | 0 | $0 |
| 2008 | PARD | 143,200 | $414,135 | 0 | $0 | 0 | $0 |
| 2007 | PARD | 86,534 | $543,580 | 0 | $0 | 0 | $0 |
| 2006 | PARD | 1,792,054 | $1,254,437 | 0 | $0 | 0 | $0 |
Insider trading activities at 3 companies by Craves Fred B:
1. Madrigal Pharmaceuticals, Inc. (MDGL)
2. Dermira, Inc. (DERM)
3. Neorx Corp (PARD)
Table 1. Insider trading of Madrigal Pharmaceuticals, Inc. (MDGL) by Craves Fred B
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-03-13 | MDGL | Option Ex | 7,742 | 65.06 | 503,694 |
| 2025-03-12 | MDGL | Sale | 7,728 | 332.58 | 2,570,178 |
| 2025-03-13 | MDGL | Sale | 7,742 | 326.58 | 2,528,366 |
| 2025-03-12 | MDGL | Option Ex | 7,728 | 88.06 | 680,527 |
| 2024-12-03 | MDGL | Sale | 3,600 | 315.56 | 1,136,008 |
| 2024-05-14 | MDGL | Sale | 22,489 | 215.40 | 4,844,220 |
| 2024-05-14 | MDGL | Option Ex | 22,489 | 102.77 | 2,311,082 |
| 2020-08-19 | MDGL | Sale | 7,303 | 107.64 | 786,094 |
| 2020-08-18 | MDGL | Sale | 10,197 | 110.03 | 1,121,975 |
| 2020-08-17 | MDGL | Sale | 12,500 | 110.73 | 1,384,125 |
| 2019-12-13 | MDGL | Sale | 1,200,000 | 105.47 | 126,564,000 |
| 2018-11-19 | MDGL | Buy | 2,000 | 124.25 | 248,494 |
| 2018-06-11 | MDGL | Sale | 280,000 | 287.46 | 80,488,800 |
Table 2. Insider trading of Dermira, Inc. (DERM) by Craves Fred B
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-06-12 | DERM | Option Ex | 3,000 | .00 | 0 |
| 2018-06-13 | DERM | Option Ex | 3,000 | .00 | 0 |
| 2017-08-10 | DERM | Buy | 20,000 | 22.57 | 451,480 |
| 2017-08-14 | DERM | Buy | 10,000 | 23.95 | 239,460 |
| 2014-10-08 | DERM | Buy | 69,112 | 16.00 | 1,105,792 |
Table 3. Insider trading of Neorx Corp (PARD) by Craves Fred B
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2011-06-09 | PARD | Option Ex | 36,145 | .00 | 0 |
| 2009-03-26 | PARD | Buy | 15,000 | 2.09 | 31,409 |
| 2009-03-27 | PARD | Buy | 5,000 | 2.13 | 10,674 |
| 2008-12-19 | PARD | Buy | 25,000 | 1.75 | 43,775 |
| 2008-12-22 | PARD | Buy | 2,900 | 1.77 | 5,133 |
| 2008-12-18 | PARD | Buy | 26,500 | 1.89 | 50,085 |
| 2008-12-17 | PARD | Buy | 13,000 | 1.92 | 24,999 |
| 2008-12-16 | PARD | Buy | 11,900 | 1.95 | 23,240 |
| 2008-01-11 | PARD | Buy | 12,600 | 3.94 | 49,656 |
| 2008-01-09 | PARD | Buy | 20,000 | 4.21 | 84,200 |
| 2008-01-04 | PARD | Buy | 11,300 | 4.19 | 47,347 |
| 2008-01-03 | PARD | Buy | 20,000 | 4.29 | 85,700 |
| 2007-08-30 | PARD | Buy | 5,344 | 5.80 | 30,973 |
| 2007-08-29 | PARD | Buy | 352 | 5.75 | 2,022 |
| 2007-08-16 | PARD | Buy | 327 | 5.48 | 1,792 |
| 2007-08-14 | PARD | Buy | 41 | 5.50 | 225 |
| 2007-08-10 | PARD | Buy | 972 | 5.50 | 5,346 |
| 2007-04-30 | PARD | Buy | 79,498 | 6.33 | 503,222 |
| 2006-04-26 | NERX | Buy | 1,792,054 | .70 | 1,254,437 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Craves Fred B
(Director of Madrigal Pharmaceuticals, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.